The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:1036-1038 April 1, 1999 Number 13
NextNext

Bronchopulmonary Dysplasia — No Simple Solution

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Cole, C. H.
-PubMed Citation
Progress in the treatment of neonates with the respiratory distress syndrome has been one of the medical success stories of the past 15 years. During this time, the widespread use of glucocorticoids to accelerate lung maturation, surfactant therapy, and improved methods of ventilation have drastically improved the outlook for these infants, so that preterm infants with birth weights between 500 and 750 g now have at least a 50 percent chance of survival.1 Unfortunately, a chronic neonatal lung disease called bronchopulmonary dysplasia develops in half the infants who survive, posing a challenge for clinicians and researchers alike.

When first described . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.